JS1-1-01 Tablet

· Tasly Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JS1-1-01 Tablet, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression [Phase 2, Phase 3]

See pricing